| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning health.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Illinois Sexually Transmissible Disease | |||||||||||||||||||
5 | Control Act is amended by changing Section 6 as follows:
| |||||||||||||||||||
6 | (410 ILCS 325/6) (from Ch. 111 1/2, par. 7406)
| |||||||||||||||||||
7 | Sec. 6. Physical examination and treatment.
| |||||||||||||||||||
8 | (a) Subject to the provisions of subsection (c) of this | |||||||||||||||||||
9 | Section, the
Department and its authorized representatives may | |||||||||||||||||||
10 | examine or cause to be
examined persons reasonably believed to | |||||||||||||||||||
11 | be infected with or to have been
exposed to a sexually | |||||||||||||||||||
12 | transmissible disease.
| |||||||||||||||||||
13 | (b) Subject to the provisions of subsection (c) of this | |||||||||||||||||||
14 | Section, persons
with a sexually transmissible disease shall | |||||||||||||||||||
15 | report for complete treatment to a
physician licensed under | |||||||||||||||||||
16 | the provisions of the Medical Practice Act of
1987, or shall | |||||||||||||||||||
17 | submit to treatment at a facility provided by a local health
| |||||||||||||||||||
18 | authority or other public facility, as the Department shall | |||||||||||||||||||
19 | require by rule or
regulation until the disease is | |||||||||||||||||||
20 | noncommunicable or the Department determines
that the person | |||||||||||||||||||
21 | does not present a real and present danger to the public
| |||||||||||||||||||
22 | health. This subsection (b) shall not be construed to require | |||||||||||||||||||
23 | the Department
or local health authorities to pay for or |
| |||||||
| |||||||
1 | provide such treatment.
| ||||||
2 | (c) No person shall be apprehended, examined or treated | ||||||
3 | for a sexually
transmissible disease against his will, under | ||||||
4 | the provisions of this Act,
except upon the presentation of a | ||||||
5 | warrant duly authorized by a court of
competent jurisdiction. | ||||||
6 | In requesting the issuance of such a warrant the
Department | ||||||
7 | shall show by a preponderance of evidence that the person is
| ||||||
8 | infectious and that a real and present danger to the public | ||||||
9 | health and
welfare exists unless such warrant is issued and | ||||||
10 | shall show that all other
reasonable means of obtaining | ||||||
11 | compliance have been exhausted and that no
other less | ||||||
12 | restrictive alternative is available. The court shall require
| ||||||
13 | any proceedings authorized by this subsection (c) to be | ||||||
14 | conducted in
camera. A record shall be made of such | ||||||
15 | proceedings but shall be sealed,
impounded and preserved in | ||||||
16 | the records of the court, to be made available
to the reviewing | ||||||
17 | court in the event of an appeal.
| ||||||
18 | (d) Any person who knowingly or maliciously disseminates | ||||||
19 | any false
information or report concerning the existence of | ||||||
20 | any sexually
transmissible disease under this Section is | ||||||
21 | guilty of a Class A misdemeanor.
| ||||||
22 | (e) Taking into account the recommendations of the U.S. | ||||||
23 | Centers for Disease Control and Prevention and other | ||||||
24 | nationally recognized medical authorities, the Department | ||||||
25 | shall provide information and technical assistance as | ||||||
26 | appropriate to health care professionals who provide expedited |
| |||||||
| |||||||
1 | partner therapy services for persons with sexually | ||||||
2 | transmissible diseases. | ||||||
3 | (1) Notwithstanding any other provision of law, a | ||||||
4 | health care professional who makes a clinical diagnosis of | ||||||
5 | chlamydia , or gonorrhea , or trichomoniasis may prescribe, | ||||||
6 | dispense, furnish, or otherwise provide prescription | ||||||
7 | antibiotic drugs to the infected person's sexual partner | ||||||
8 | or partners for the treatment of the sexually | ||||||
9 | transmissible disease without physical examination of the | ||||||
10 | partner or partners, if in the judgment of the health care | ||||||
11 | professional the partner is unlikely or unable to present | ||||||
12 | for comprehensive healthcare, including evaluation, | ||||||
13 | testing, and treatment for sexually transmissible | ||||||
14 | diseases. Expedited partner therapy shall be limited to | ||||||
15 | partners who may have been exposed to a sexually | ||||||
16 | transmissible disease within the previous 60 days, if the | ||||||
17 | patient is able to contact the partner. | ||||||
18 | (2) Health care professionals who provide expedited | ||||||
19 | partner therapy shall comply with Sections 4 and 5 of the | ||||||
20 | Illinois Sexually Transmissible Disease Control Act. | ||||||
21 | (3) Health care professionals who provide expedited | ||||||
22 | partner therapy shall provide counseling for the patient | ||||||
23 | and written materials provided by the Department to be | ||||||
24 | given by the patient to the partner or partners that | ||||||
25 | include at a minimum the following: | ||||||
26 | (A) a warning that a woman who is pregnant or might |
| |||||||
| |||||||
1 | be pregnant must not take certain antibiotics and must | ||||||
2 | immediately contact a health care professional for an | ||||||
3 | examination, and a recommendation for such an | ||||||
4 | examination; | ||||||
5 | (B) information about the antibiotic and dosage | ||||||
6 | provided or prescribed; clear and explicit allergy and | ||||||
7 | side effect warnings, including a warning that a | ||||||
8 | partner who has a history of allergy to the antibiotic | ||||||
9 | or the pharmaceutical class of antibiotic must not | ||||||
10 | take the antibiotic and must be immediately examined | ||||||
11 | by a health care professional, and a recommendation | ||||||
12 | for such an examination; | ||||||
13 | (C) information about the treatment and prevention | ||||||
14 | of sexually transmissible diseases; | ||||||
15 | (D) the requirement of abstinence until a period | ||||||
16 | of time after treatment to prevent infecting others; | ||||||
17 | (E) notification of the importance of the partner | ||||||
18 | or partners of the patient to receive examination and | ||||||
19 | testing for HIV and other sexually transmissible | ||||||
20 | diseases, and available resources; | ||||||
21 | (F) notification of the risk to self, others, and | ||||||
22 | the public health if the sexually transmissible | ||||||
23 | disease is not completely and successfully treated; | ||||||
24 | (G) the responsibility of the partner or partners | ||||||
25 | to inform his or her sex partner or partners of the | ||||||
26 | risk of sexually transmissible disease and the |
| |||||||
| |||||||
1 | importance of prompt examination and treatment; and | ||||||
2 | (H) other information as deemed necessary by the | ||||||
3 | Department. | ||||||
4 | (4) The Department shall develop and disseminate in | ||||||
5 | electronic and other formats the following written | ||||||
6 | materials: | ||||||
7 | (A) informational materials for partners, as | ||||||
8 | required in item (3) of this subsection (e); | ||||||
9 | (B) informational materials for persons who are | ||||||
10 | repeatedly diagnosed with sexually transmissible | ||||||
11 | diseases; and | ||||||
12 | (C) guidance for health care professionals on the | ||||||
13 | safe and effective provision of expedited partner | ||||||
14 | therapy. | ||||||
15 | The Department may offer educational programs about | ||||||
16 | expedited partner therapy for health care professionals | ||||||
17 | and pharmacists licensed under the Pharmacy Practice Act. | ||||||
18 | (5) A health care professional prescribing, | ||||||
19 | dispensing, furnishing, or otherwise providing in good | ||||||
20 | faith without fee or compensation prescription antibiotics | ||||||
21 | to partners under this subsection (e) and providing | ||||||
22 | counseling and written materials as required by item (3) | ||||||
23 | of this subsection (e) shall not be subject to civil or | ||||||
24 | professional liability, except for willful and wanton | ||||||
25 | misconduct. A health care professional shall not be | ||||||
26 | subject to civil or professional liability for choosing |
| |||||||
| |||||||
1 | not to provide expedited partner therapy. | ||||||
2 | (6) A pharmacist or pharmacy shall not be subject to | ||||||
3 | civil or professional liability for choosing not to fill a | ||||||
4 | prescription that would cause the pharmacist or pharmacy | ||||||
5 | to violate any provision of the Pharmacy Practice Act, | ||||||
6 | including the definition of "prescription" set forth in | ||||||
7 | subsection (e) of Section 3 of the Pharmacy Practice Act | ||||||
8 | or the definition of "drug regimen review" set forth in | ||||||
9 | subsection (y) of Section 3 of the Pharmacy Practice Act. | ||||||
10 | (Source: P.A. 96-613, eff. 1-1-10.)
|